Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Caterina F Donini"'
Autor:
Caterina F. Donini, Myriam El Helou, Anne Wierinckx, Balázs Győrffy, Sophie Aires, Aurélie Escande, Séverine Croze, Philippe Clezardin, Joël Lachuer, Mona Diab-Assaf, Sandra E. Ghayad, Béatrice Fervers, Vincent Cavaillès, Véronique Maguer-Satta, Pascale A. Cohen
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
It is of utmost importance to decipher the role of chronic exposure to low doses of environmental carcinogens on breast cancer progression. The early-transformed triple-negative human mammary MCF10AT1 cells were chronically (60 days) exposed to low d
Externí odkaz:
https://doaj.org/article/9deef468b8a74ab58e8ea72c1647ba1c
Autor:
Julie A. Vendrell, Jérôme Solassol, Balázs Győrffy, Paul Vilquin, Marta Jarlier, Caterina F. Donini, Laurent Gamba, Thierry Maudelonde, Philippe Rouanet, Pascale A. Cohen
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2019)
ZNF217 is a candidate oncogene with a wide variety of deleterious functions in breast cancer. Here, we aimed at investigating in a pilot prospective study the association between ZNF217 mRNA expression levels and the clinical response to neoadjuvant
Externí odkaz:
https://doaj.org/article/546e9460c02d4994a31a86b0aaae76bf
Autor:
Irma Machuca-Gayet, Balázs Győrffy, Olivier Peyruchaud, Evelyne Grisard, Maëva Ruel, Aurélie Bellanger, Pascale A. Cohen, Jean-Luc Coll, Isabelle Treilleux, Ivan Bièche, Julien Vollaire, Véronique Josserand, Véronique Maguer-Satta, Jonathan Lavaud, Caterina F Donini, Julie A. Vendrell
Publikováno v:
The Journal of Pathology. 242:73-89
Bone metastasis affects >70% of patients with advanced breast cancer. However, the molecular mechanisms underlying this process remain unclear. On the basis of analysis of clinical datasets, and in vitro and in vivo experiments, we report that the ZN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ba50e4d85c9c33ca72d75cad00dc4da
https://doi.org/10.1002/path.4882
https://doi.org/10.1002/path.4882
Autor:
Pascale A. Cohen, Xinyi Xu, Véronique Maguer-Satta, Alice Clement, Isabelle Treilleux, Soleilmane Omarjee, Muriel Le Romancer, Emmanuel Delay, Caterina F Donini, Béatrice Fervers, Flora Clément
Publikováno v:
Cell Death and Differentiation
Bone morphogenetic protein 2 (BMP2) and BMP4 are key regulators of the fate and differentiation of human mammary epithelial stem cells (SCs), as well as of their niches, and are involved in breast cancer development. We established that MCF10A immatu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ceac071ad50ca425d5a9ab42ff4203
https://doi.org/10.1038/cdd.2016.107
https://doi.org/10.1038/cdd.2016.107
Autor:
Aurélie, Bellanger, Caterina F, Donini, Julie A, Vendrell, Jonathan, Lavaud, Irma, Machuca-Gayet, Maëva, Ruel, Julien, Vollaire, Evelyne, Grisard, Balázs, Győrffy, Ivan, Bièche, Olivier, Peyruchaud, Jean-Luc, Coll, Isabelle, Treilleux, Véronique, Maguer-Satta, Véronique, Josserand, Pascale A, Cohen
Publikováno v:
The Journal of pathology. 242(1)
Bone metastasis affects70% of patients with advanced breast cancer. However, the molecular mechanisms underlying this process remain unclear. On the basis of analysis of clinical datasets, and in vitro and in vivo experiments, we report that the ZNF2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c56eaa6480bccdb3955edd5d2e1cb0ca
https://pubmed.ncbi.nlm.nih.gov/28207159
https://pubmed.ncbi.nlm.nih.gov/28207159
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2015, 6 (39), pp.41566-81. ⟨10.18632/oncotarget.5893⟩
Oncotarget, 2015, 6 (39), pp.41566-81. ⟨10.18632/oncotarget.5893⟩
Oncotarget, Impact journals, 2015, 6 (39), pp.41566-81. ⟨10.18632/oncotarget.5893⟩
Oncotarget, 2015, 6 (39), pp.41566-81. ⟨10.18632/oncotarget.5893⟩
International audience; The recently described oncogene ZNF217 belongs to a chromosomal region that is frequently amplified in human cancers. Recent findings have revealed that alternative mechanisms such as epigenetic regulation also govern the expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdc2aabdee8037557cd7b336ccac81d
https://www.hal.inserm.fr/inserm-01427161/document
https://www.hal.inserm.fr/inserm-01427161/document
Autor:
Pascale A. Cohen, Laura Corbo, Paul Vilquin, Thomas Bachelot, Julie A. Vendrell, Marie Villedieu, Caterina F Donini, E. Grisard
Publikováno v:
Breast Cancer Research : BCR
Introduction Increasing evidence indicates that microRNAs (miRNAs) are important players in oncogenesis. Considering the widespread use of aromatase inhibitors (AIs) in endocrine therapy as a first-line treatment for postmenopausal estrogen receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd76a4c6e673f109f929835dc671b30
https://pubmed.ncbi.nlm.nih.gov/25633049
https://pubmed.ncbi.nlm.nih.gov/25633049
Autor:
Antonio Porcellini, Marina Di Domenico, Candida Zuchegna, Erika Di Zazzo, Caterina Francesca Donini, Sonia D'Inzeo, Arianna Nicolussi, Anna Coppa, Enrico V. Avvedimento
Phosphoinositide-3-OH kinase (PI3K) signalling regulates various cellular processes, including cell survival, growth, proliferation and motility, and is among the most frequently mutated pathways in cancer. Although the involve- ment of p85αPI3K SH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fba6b32fe3d41166a735c10eb69228
http://hdl.handle.net/11573/436094
http://hdl.handle.net/11573/436094